[1] |
Nicolaides KH, Snijders RJ, Gosden CM, et al. Ultrasonographically detectable markers of fetal chromosomal abnormalities[J]. Lancet, 1992, 340(8821): 704-707. DOI: 10.1016/0140-6736(92)92240-g.
|
[2] |
Burger NB, Bekker MN, de Groot CJ, et al. Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms[J]. Prenat Diagn, 2015, 35(6): 517-528. DOI: 10.1002/pd.4586.
|
[3] |
Hellmuth SG, Pedersen LH, Miltoft CB, et al. Increased nuchal translucency thickness and risk of neurodevelopmental disorders[J]. Ultrasound Obstet Gynecol, 2017, 49(5): 592-598. DOI: 10.1002/uog.15961.
|
[4] |
Ali MM, Chasen ST, Norton ME. Testing for Noonan syndrome after increased nuchal translucency[J]. Prenat Diagn, 2017, 37(8): 750-753. DOI: 10.1002/pd.5076.
|
[5] |
Christiansen M, Ekelund CK, Petersen OB, et al. Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort[J]. Prenat Diagn, 2016, 36(1): 49-55. DOI: 10.1002/pd.4711.
|
[6] |
Herrera LG, Royero LR, Rodríguez NG, et al. Effectiveness of increased nuchal translucency in detecting pregnancies at risk for chromosomal abnormalities[J]. MediSur, 2014, 12(1): 63-76.
|
[7] |
Socolov D, Socolov R, Gorduza VE, et al. Increased nuchal translucency in fetuses with a normal karyotype-diagnosis and management: an observational study[J]. Medicine (Baltimore), 2017, 96(29): e7521. DOI: 10.1097/MD.0000000000007521.
|
[8] |
Grubman O, Hussain FN, Nelson Z, et al. Maternal Parvovirus B19 infection causing first-trimester increased nuchal translucency and fetal hydrops[J]. Case Rep Obstet Gynecol, 2019, 2019: 3259760. DOI: 10.1155/2019/3259760.
|
[9] |
Michailidis GD, Economides DL. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses[J]. Ultrasound Obstet Gynecol, 2001, 17(2): 102-105. DOI: 10.1046/j.1469-0705.2001.00341.x.
|
[10] |
Tiyatha S, Sirilert S, Sekararithi R, et al. Association between unexplained thickened nuchal translucency and adverse pregnancy outcomes[J]. Arch Gynecol Obstet, 2018, 298(1): 97-101. DOI: 10.1007/s00404-018-4790-9.
|
[11] |
Moczulska H, Janiak K, Sodki M, et al. Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency[J]. J Ultrason, 2013, 13(52): 21-30. DOI: 10.15557/JoU.2013.0002.
|
[12] |
Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype[J]. Am J Obstet Gynecol, 2005, 192(4): 1005-1021. DOI: 10.1016/j.ajog.2004.12.093.
|
[13] |
Pandya PP, Kondylios A, Hilbert L, et al. Chromosomal defects and outcome in 1 015 fetuses with increased nuchal translucency[J]. Ultrasound Obstet Gynecol, 1995, 5(1): 15-19. DOI: 10.1046/j.1469-0705.1995.05010015.x.
|
[14] |
Tekesin I. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness[J]. J Perinat Med, 2019, 47(2): 241-246. DOI: 10.1515/jpm-2018-0145.
|